164 related articles for article (PubMed ID: 10485021)
1. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia.
Lund VJ; Howard DJ
Am J Rhinol; 1999; 13(4):319-22. PubMed ID: 10485021
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
3. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
Choi JW; Joo YH; Jeong WS; Jang YJ
Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
5. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia.
Lund VJ; Howard DJ
J Laryngol Otol; 1997 Jan; 111(1):30-3. PubMed ID: 9292127
[TBL] [Abstract][Full Text] [Related]
6. [Epistaxis in patients with hereditary hemorrhagic teleangiectasia].
Jovancević L; Mitrović SM
Med Pregl; 2006; 59(9-10):443-9. PubMed ID: 17345820
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients.
Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B
J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
Lennox PA; Harries M; Lund VJ; Howard DJ
J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
[TBL] [Abstract][Full Text] [Related]
9. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
10. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
11. Technique modifications for septodermoplasty: an illustrative case.
Bastianelli M; Kilty SJ
J Otolaryngol Head Neck Surg; 2015 Dec; 44():59. PubMed ID: 26714786
[TBL] [Abstract][Full Text] [Related]
12. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
[TBL] [Abstract][Full Text] [Related]
13. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
Ghaheri BA; Fong KJ; Hwang PH
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
[TBL] [Abstract][Full Text] [Related]
14. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
15. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Siegel MB; Keane WM; Atkins JF; Rosen MR
Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
[TBL] [Abstract][Full Text] [Related]
16. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Fiorella ML; Ross D; Henderson KJ; White RI
Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
Sautter NB; Smith TL
Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent epistaxis in HHT.
Geisthoff UW; Fiorella ML; Fiorella R
Curr Pharm Des; 2006; 12(10):1237-42. PubMed ID: 16611115
[TBL] [Abstract][Full Text] [Related]
19. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
20. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Luk L; Mace JC; Bhandarkar ND; Sautter NB
Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]